Patent ID: 8802087
Filing Date: 2014-08-12
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition for oral administration as a solid dosage form, comprising an active pharmaceutical agent and a surfactant system, which is self-emulsifiable on contact with a hydrophilic phase and a lipophilic phase, said composition comprising: (i) an active pharmaceutical agent which (ii) wherein the surfactant system comprises a. a surfactant in an amount of 2% to 90% by weight of the surfactant system selected from either a first group or an ionic surfactant, wherein the first group consists of: polyethylene glycol fatty acid mono-esters and/or di-esters with aliphatic C b. a co-surfactant in an amount of 5% to 60% by weight of the surfactant system, selected from a group consisting of monoacylglycerides with aliphatic C c. a lipophilic phase in an amount of 0% to 70% by weight of the surfactant system, represented by diacylglyerides and/or triacylglycerides with aliphatic C wherein the surfactant system comprises 10% to 95% by weight of the pharmaceutical composition.